August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Targeted and Immunotherapy Strategies in NSCLC Explored by ESMO
Jun 26, 2025, 09:14

Targeted and Immunotherapy Strategies in NSCLC Explored by ESMO

ESMO – European Society for Medical Oncology shared on LinkedIn:

“Findings from the NeoADAURA and the CheckMate 816 provide novel insights on the role of neoadjuvant osimertinib and nivolumab in the perioperative setting adding to the current knowledge on how to integrate targeted and immunotherapy agents in the treatment planning.

Read the opinion by Marina Chiara Garassino in the ESMO Daily Reporter and learn what key questions remain unanswered.”

More posts featuring NSCLC.